| 标题 |
ARALU - Phase 2, Open-label, Randomized Study to Investigate Safety and Efficacy of Pluvicto Therapy in Patients with Metastatic Hormone-sensitive Prostate Cancer in Addition to Standard of Care Treatment with Nubeqa and ADT
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 | Franz J, Brumberg J, Mix M, Meyer PT, Herrmann K, Gratzke C, Sigle A. ARALU - Phase 2, Open-label, Randomized Study to Investigate Safety and Efficacy of Pluvicto Therapy in Patients with Metastatic Hormone-sensitive Prostate Cancer in Addition to Standard of Care Treatment with Nubeqa and ADT. Eur Urol Focus. 2026 Jul 15:S2405-4569(26)00119-7. doi: 10.1016/j.euf.2026.06.023. Epub ahead of print. PMID: 42457482. |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)